Functional consequences of neuropeptide FF receptors stimulation in mouse: A cerebral glucose uptake study

Neuroscience

Volumn 126, Issue 2, 2004, Pages 441-449

  Quelven, I ^a   Roussin, A ^a   Zajac, J M ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

1DMe; 2 deoxyglucose uptake; CNS; locomotor activity; morphine; mouse; neuropeptide FF; neuropeptide Phe Leu Phe Gln Pro Gln Arg Phe NH2; NPFF; photo stimulated luminescence surface unit; PSL S; ventral tegmental area; VTA

Indexed keywords

DEOXYGLUCOSE; MORPHINE; NEUROPEPTIDE FF; NEUROPEPTIDE RECEPTOR; OPIATE RECEPTOR; TYROSINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CEREBELLUM CORTEX; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PAIN; PAIN ASSESSMENT; PERIAQUEDUCTAL GRAY MATTER; PONS RETICULAR FORMATION; PRIORITY JOURNAL; PUTAMEN; SENSORY ANALYSIS; SOMATOSENSORY CORTEX; SPINAL CORD; STATISTICAL SIGNIFICANCE; SUPERIOR COLLICULUS; THALAMUS;

ANIMALS; BRAIN; DEOXYGLUCOSE; MALE; MICE; MORPHINE; MOTOR ACTIVITY; RECEPTORS, NEUROPEPTIDE;

EID: 2942683214     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.03.052     Document Type: Article

References (43)

1. Allard M., Zajac J.-M., Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience. 49:1992;101-116
2. Attila M., Kurkijarvi U., Kivipelto L., Panula P., Ahtee L. The antiopioid peptide, neuropeptide FF, enhances the effects of acute morphine on the cerebral monoamines in rats. Pharmacol Res. 32:1995;293-298
3. Ballet S., Mauborgne A., Gouarderes C., Bourgoin A.S., Zajac J.-M., Hamon M., Cesselin F. The neuropeptide FF analogue, 1DMe, enhances in vivo met-enkephalin release from the rat spinal cord. Neuropharmacology. 38:1999;1317-1324
4. Beck T., Wenzel J., Kuschinsky K., Krieglstein J. Morphine-induced alterations of local cerebral glucose utilization in the basal ganglia of rats. Brain Res. 497:1989;205-213
5. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., Smith K.E., Tamm J.A., Boteju L.W., Lakhlani P.P., Raddatz R., Yao W.J., Ogozalek K.L., Boyle N., Kouranova E.V., Quan Y., Vaysse P.J., Wetzel J.M., Branchek T.A., Gerald C., Borowsky B. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem. 275:2000;39324-39331
6. Bonnard E., Burlet-Schiltz O., Frances B., Mazarguil H., Monsarrat B., Zajac J.-M., Roussin A. Identification of neuropeptide FF-related peptides in rodent spinal cord. Peptides. 22:2001;1085-1092
7. Bonnard E., Burlet-Schiltz O., Monsarrat B., Girard J.-P., Zajac J.-M. Identification of proNeuropeptide FFA peptides processed in neuronal and non-neuronal cells and in nervous tissue. Eur J Biochem. 270:2003;4187-4199
8. Burlet-Schiltz O., Mazarguil H., Sol J.C., Chaynes P., Monsarrat B., Zajac J.-M., Roussin A. Identification of neuropeptide FF-related peptides in human cerebrospinal fluid by mass spectrometry. FEBS Lett. 532:2002;313-318
9. Cador M., Marco N., Stinus L., Simonnet G. Interaction between neuropeptide FF and opioids in the ventral tegmental area in the behavioral response to novelty. Neuroscience. 110:2002;309-318
10. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., Evans N.A., Schmidt D.B., Buckley P.T., Dytko G.M., Murdock P.R., Tan K.B., Shabon U., Nuthulaganti P., Wang D.Y., Wilson S., Bergsma D.J., Sarau H.M. Receptor for the pain modulatory neuropeptides NPFF and NPAF is an orphan G-protein-coupled receptor. J Biol Chem. 275:2000;25965-25971
11. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. San Diego, CA: Academic Press.
12. Gicquel S., Mazarguil H., Allard M., Simonnet G., Zajac J.-M. Analogs of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur J Pharmacol. 222:1992;61-67
13. Gouardères C., Jhamandas K., Sutak M., Zajac J.-M. Roles of opioid receptors in the spinal antinociception effects of neuropeptide FF analogues. Br J Pharmacol. 117:1996;493-501
14. 125I]EYF as selective radioligands. Neuroscience. 115:2002;349-361
15. 2) in the rat, mouse, octodon, rabbit, guinea-pig and marmoset monkey brains A comparative autoradiographic study. Synapse. 51:2004;249-269
16. Hienz R.D., Zarcone T.J., Brady J.V. Perceptual and motor effects of morphine and buprenorphine in baboons. Pharmacol Biochem Behav. 69:2001;305-313
17. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., Fujii R., Watanabe T., Kikuchi K., Terao Y., Yano T., Yamamoto T., Kawamata Y., Habata Y., Asada M., Kitada C., Kurokawa T., Onda H., Nishimura O., Tanaka M., Ibata Y., Fujino M. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol. 2:2000;703-708
18. Kelly S., Bieneman A., Uney J.B., McCulloch J. Cerebral glucose utilization in transgenic mice overexpressing heat shock protein 70 is altered by dizocilpine. Eur J Neurosci. 15:2002;945-952
19. Kotani M., Mollereau C., Detheux M., Le Poul E., Brezillon S., Vakili J., Mazarguil H., Vassart G., Zajac J.-M., Parmentier M. Functional characterization of a human receptor for neuropeptide FF and related peptides. Br J Pharmacol. 133:2001;138-144
20. Kuzmin A., Sandin J., Terenius L., Ogren S.O. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice. J Pharmacol Exp Ther. 295:2000;1031-1042
21. Lee E.H.Y., Tsai M.J. The hippocampus and amygdala mediate the locomotor stimulating effects of corticotropin-releasing factor in mice. Behav Neural Biol. 51:1989;412-423
22. Lellouch J, Lazar P (1996) Méthodes statistiques en expérimentation biologique. Paris: Flammarion Médecine-Sciences.
23. Liu Q., Guan X.M., Martin W.J., McDonald T.P., Clements M.K., Jiang Q., Zeng Z., Jacobson M., Williams D.L. Jr, Yu H., Bomford D., Figueroa D., Mallee J., Wang R., Evans J., Gould R., Austin C.P. Identification and characterization of novel mammalian neuropeptide FF- like peptides that attenuate morphine-induced antinociception. J Biol Chem. 40:2001;36961-36969
24. Marco N., Stinus L., Allard M., Le Moal M., Simonnet G. Neuropeptide FLFQRFamide receptors within the ventral mesencephalon and dopaminergic terminal areas Localization and functional antiopioid involvement. Neuroscience. 64:1995;1035-1044
25. Mauborgne A., Bourgoin S., Polienor H., Roumy M., Simonnet G., Zajac J.-M., Cesselin F. The neuropeptide FF analogue, 1DMe, acts as a functional opioid autoreceptor antagonist in the rat spinal cord. Eur J Pharmacol. 430:2001;273-276
26. Mazarguil H., Gouardères C., Tafani J.-A.M., Marcus D., Kotani M., Mollereau C., Zajac J.-M. Structure-activity relationships of neuropeptide FF Role of c-terminal regions. Peptides. 22:2001;1471-1478
27. Meibach R.C., Glick S.D., Ross D.A., Cox R.D., Maayani S. Intraperitoneal administration and other modifications of the 2-deoxy-D-glucose technique. Brain Res. 195:1980;167-176
28. Melzacka M., Nesselhut T., Havemann U., Vetulani J., Kuschinsky K. Pharmacokinetics of morphine in striatum and nucleus accumbens Relationship to pharmacological actions. Pharmacol Biochem Behav. 23:1985;295-301
29. Michael-Titus A., Dourmap N., Costentin J. Mu and delta opioid receptors control differently the horizontal and vertical components of locomotor activity in mice. Neuropeptides. 13:1989;235-242
30. Ohno T., Kanazawa I. Mapping of the neural activity in the cerebellum of the mouse during stepping by means of 2-deoxyglucose autoradiography. Neurosci Lett. 32:1982;119-123
31. Panula P., Aarnisalo A.A., Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog Neurobiol. 48:1996;461-487
32. Perry S.J., Huang E.Y., Cronk D., Bagust J., Sharma R., Walker R.J., Wilson S., Burke J.F. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett. 409:1997;426-430
33. Quelven I., Roussin A., Burlet-Schiltz O., Gouarderes C., Tafani J.A., Mazarguil H., Zajac J.-M. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs. Eur J Pharmacol. 449:2002;91-98
34. Roumy M., Zajac J.-M. Neuropeptide FF, pain and analgesia. Eur J Pharmacol. 345:1998;1-11
35. Roumy M., Zajac J.-M. Neuropeptide FF selectively attenuates the effects of nociceptin on acutely dissociated neurons of the rat dorsal raphe nucleus. Brain Res. 845:1999;208-214
36. Schwartzman R.J., Eidelberg E., Alexander G.M. Asymmetrical regional changes in energy metabolism of the central nervous system during walking. Brain Res. 398:1986;113-120
37. Serapide M.F., Parenti R., Panto M.R., Zappala A., Cicirata F. Multiple zonal projections of the nucleus reticularis tegmenti pontis to the cerebellar cortex of the rat. Eur J Neurosci. 15:2002;1854-1858
38. Sharp F.R., Kilduff T.S., Bzorgchami S., Heller H.C., Ryan A.F. The relationship of local cerebral glucose utilization to optical density ratios. Brain Res. 263:1983;97-103
39. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M.H., Patlak C.S., Pettigrew K.D., Sakurada O., Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization Theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 28:1977;897-916
40. Vilim F.S., Aarnisalo A.A., Nieminen M.L., Lintunen M., Karlstedt K., Kontinen V.K., Kalso E., States B., Panula P., Ziff E. Gene for pain modulatory neuropeptide NPFF Induction in spinal cord by noxious stimuli. Mol Pharmacol. 55:1999;804-811
41. Weiss E., Greenberg G. Open field procedures. Greenberg G., Haraway M.H. Comparative psychology A handbook. 1996;603-620 Garland, New York
42. Yang H.-Y.T., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA. 82:1985;7757-7761
43. Yang H-YT, Martin B-M (1995) Isolation and characterization of a neuropeptide from brain and spinal cord of rat. Proc Soc Neurosci Abstr San Diego, CA, 760.